Testing for Latent Tuberculosis in HIV Patients
Author Information
Author(s): Karam Farba, Mbow Fatou, Fletcher Helen, Senghor Cheikh S., Coulibaly Koura D., LeFevre Andrea M., Ngom Gueye Ndeye F., Dieye Tandakha, Sow Papa S., Mboup Souleymane, Lienhardt Christian
Primary Institution: Laboratoire de Bactériologie – Virologie, Hôpital Aristide Le Dantec, Dakar, Senegal
Hypothesis
Can a new interferon-γ release assay (IGRA) effectively detect latent tuberculosis infection (LTBI) in HIV-infected individuals compared to the Tuberculin Skin Test (TST)?
Conclusion
The study found that the IGRA is more sensitive than the TST for diagnosing LTBI in HIV-positive individuals, but its effectiveness decreases with advanced immuno-suppression.
Supporting Evidence
- The EC ELISPOT assay was positive in 50.6% of subjects, while the TST was positive in only 21.5%.
- Concordance between EC ELISPOT and TST was observed in 61.1% of patients.
- The proportion of positive responses to the EC ELISPOT decreased with declining CD4 counts.
Takeaway
This study shows that a new test can better find tuberculosis in people with HIV, but it might not work as well if their immune system is very weak.
Methodology
The study used an in-house ELISPOT assay and TST on 285 HIV-infected individuals to compare the effectiveness of both tests in detecting LTBI.
Potential Biases
Potential biases may arise from the selection of participants and the reliance on self-reported data.
Limitations
The study may not generalize to all HIV-infected populations, especially those with different levels of immuno-suppression.
Participant Demographics
The cohort included 115 males and 170 females with a median age of 37 years.
Statistical Information
P-Value
p=0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website